Coston McIsaac & Partners’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Buy |
+11
| New | – | ﹤0.01% | 759 |
|
|
2025
Q1 | – | Sell |
-10
| Closed | – | – | 756 |
|
|
2024
Q4 | $0 | Hold |
10
| – | – | ﹤0.01% | 752 |
|
|
2024
Q3 | $0 | Hold |
10
| – | – | ﹤0.01% | 755 |
|
|
2024
Q2 | $0 | Hold |
10
| – | – | ﹤0.01% | 735 |
|
|
2024
Q1 | $0 | Hold |
10
| – | – | ﹤0.01% | 718 |
|
|
2023
Q4 | $0 | Hold |
10
| – | – | ﹤0.01% | 719 |
|
|
2023
Q3 | $0 | Hold |
10
| – | – | ﹤0.01% | 720 |
|
|
2023
Q2 | $0 | Hold |
10
| – | – | ﹤0.01% | 767 |
|
|
2023
Q1 | $0 | Hold |
10
| – | – | ﹤0.01% | 797 |
|
|
2022
Q4 | $0 | Hold |
10
| – | – | ﹤0.01% | 767 |
|
|
2022
Q3 | $0 | Hold |
10
| – | – | ﹤0.01% | 686 |
|
|
2022
Q2 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 445 |
|